Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

These data show the vaccine’s potential to help protect a broader group of adults at risk from the potentially serious consequences of RSV. In the US alone, the number of adults aged 18-49 with ...

When Rose Levy Beranbaum’s “Cake Bible” was first published in 1988, it was as though the wheel had been re-invented. Sure, there were other books devoted to cakes (many of them excellent ...

experiences with all 3 of her children. Now she's trying to warn others about RSV. (Photo: Gabrielle Hopkins Photography/Courtesy of Shawn Johnson East) As a 2007 World Champion and 2008 Olympic ...

As winter's chill sweeps across the nation, health experts have urged Brits to brace for a 'tripledemic', with a likely uptick in cases of covid, flu, and RSV. Brits are urged to get vaccinated ...

The FDA has endorsed Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo for adults ages 18 to 59 who are at an increased risk of developing lower respiratory tract disease (LRTD).

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

Pfizer’s Abryso is designed to stimulate an immune response against RSV prefusion conformation (pre-F), thereby providing protection against lower respiratory tract disease caused by RSV. Image credit ...

Abrysvo is now approved for adults aged 18-59 years at increased risk for RSV due to chronic conditions, expanding its previous indications. The FDA's decision is based on a phase 3 trial showing ...

The U.S. is entering the second RSV season in which vaccines for the virus are available for older adults. Yet, despite three options on the market from Pfizer, GSK and Moderna, uptake has been slow ...

Ottawa Public Health (OPH) is recommending that eligible residents at higher risk of severe illness protect themselves against respiratory syncytial virus (RSV) this respiratory illness season. RSV is ...

Health experts are urging Brits to expect a potential surge in cases of covid, flu, and RSV. It is important to get vaccinated and know the differences between each illness and its symptoms.